Knowles M, Gatzy J, Boucher R
N Engl J Med. 1981 Dec 17;305(25):1489-95. doi: 10.1056/NEJM198112173052502.
To investigate respiratory epithelial function in cystic fibrosis, we measured the transepithelial electrical potential difference across the upper and lower respiratory mucosa in patients with cystic fibrosis and control subjects. The nasal potential difference in the 24 patients with cystic fibrosis exceeded by more than 3 standard deviations the mean voltage in healthy controls, subjects with other diseases, and subjects heterozygous for cystic fibrosis. Potential differences in lower airways were measured in four patients and were significantly greater than in controls (P less than 0.05). Superfusion of the luminal surface with amiloride, an inhibitor of active sodium absorption, induced greater reductions in both nasal and airway potential difference in patients than in controls. We conclude that the increased respiratory-epithelial potential differences appear to be a specific abnormality in homozygotes for cystic fibrosis. The greater reduction in potential difference in response to amiloride suggests that absorption of excess salt and perhaps liquid from respiratory epithelial surfaces contributes to the pathogenesis of lung disease in cystic fibrosis.
为了研究囊性纤维化患者的呼吸道上皮功能,我们测量了囊性纤维化患者和对照受试者上下呼吸道黏膜的跨上皮电位差。24例囊性纤维化患者的鼻电位差超过健康对照者、患有其他疾病的受试者以及囊性纤维化杂合子受试者的平均电压3个以上标准差。对4例患者的下呼吸道电位差进行了测量,结果显著高于对照组(P<0.05)。用活性钠吸收抑制剂氨氯吡咪灌注管腔表面,与对照组相比,患者的鼻和气道电位差降低幅度更大。我们得出结论,呼吸道上皮电位差增加似乎是囊性纤维化纯合子的一种特异性异常。氨氯吡咪引起的电位差更大幅度降低表明,呼吸道上皮表面过量盐分甚至液体的吸收在囊性纤维化肺病发病机制中起作用。